Most Active InvestorsFind investorsPricing
Start for free
Start for free
The Longevity Fund logo

The Longevity Fund

North America, California, United States, San Francisco

Description

The Longevity Fund is investing in human longevity.

Investor Profile

The Longevity Fund has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 5% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Seed (42%)
  • Series A (37%)
  • Series B (11%)
  • Series C (11%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Genetics
  • Medical Device
  • Pet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Longevity Fund frequently co-invest with?

venBio Partners
venBio Partners
North America, California, United States, San Francisco
Co-Investments: 3
First Round Capital
First Round Capital
North America, California, United States, San Francisco
Co-Investments: 4
Amgen Ventures
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
BoxGroup
BoxGroup
North America, New York, United States, New York
Co-Investments: 2
OUP (Osage University Partners)
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Bold Capital Partners
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 2
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does The Longevity Fund often collaborate with?

CS
Chloe Sladden
North America, California, United States, San Francisco
Shared Deals: 1
EL
Edward Lando
North America, Florida, United States, Miami Beach
Shared Deals: 1
BK
Brianne Kimmel
North America, California, United States, San Francisco
Shared Deals: 2
JB
Joe Betts-Lacroix
North America, California, United States, San Francisco
Shared Deals: 1
GB
Greg Brockman
North America, California, United States, San Francisco
Shared Deals: 1
CB
Courtney Broadus
North America, California, United States, San Francisco
Shared Deals: 1
CH
Claire Hughes Johnson
North America, California, United States, San Francisco
Shared Deals: 2
AM
Ashley Mayer
North America, California, United States, San Francisco
Shared Deals: 2
AG
Avichal Garg
North America, California, United States, Stanford
Shared Deals: 1
EG
Elad Gil
North America, California, United States, San Francisco
Shared Deals: 2

What are some of recent deals done by The Longevity Fund?

Loyal

San Francisco, California, United States

Loyal is a biotechnology company developing medicines to extend dogs lifespan and maintain their quality of life.

BiotechnologyPetVeterinary
Series ASep 23, 2021
Amount Raised: $27,000,000
Circumvent

Portland, Oregon, United States

Circumvent is a biotech company

BiotechnologyHealth CarePharmaceutical
SeedDec 9, 2020
Amount Raised: $4,092,000
Rubedo Life Sciences

Sunnyvale, California, United States

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

BiotechnologyHealth CareLife Science
SeedDec 3, 2020
Amount Raised: $12,000,000
Elevian

Allston, Massachusetts, United States

Elevian develops medicines that restore youthful regenerative capacity with the potential to treat and prevent many age-related diseases.

BiopharmaBiotechnologyTherapeutics
SeedNov 24, 2020
Amount Raised: $15,000,000
Loyal

San Francisco, California, United States

Loyal is a biotechnology company developing medicines to extend dogs lifespan and maintain their quality of life.

BiotechnologyPetVeterinary
SeedJan 1, 2020
Amount Raised: $11,000,000
Epirium Bio

San Diego, California, United States

Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.

BiopharmaBiotechnologyHealth CareTherapeutics
Series ADec 18, 2019
Amount Raised: $85,000,000
Exo

Redwood City, California, United States

Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.

Health CareMedicalMedical Device
Series BAug 5, 2019
Amount Raised: $35,000,000
Deciduous Therapeutics

San Francisco, California, United States

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

BiopharmaBiotechnologyHealth Care
SeedJun 28, 2019
Amount Raised: $6,500,000
Fauna Bio

Berkeley, California, United States

Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.

BiotechnologyHealth CareHospitalMedical
SeedApr 11, 2019
Amount Raised: $4,100,000
Spring Discovery

Palo Alto, California, United States

Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePharmaceutical
Series ADec 11, 2018
Amount Raised: $18,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator